Date Filed | Type | Description |
10/06/2023 |
8-K
| Other Events Interactive Data |
10/05/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
10/04/2023 |
4
| Boyer David W. (Chief Corp. Affairs Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Sold 1,437 shares
@ $112.68, valued at
$161.9k
|
|
10/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/23/2023 |
4
| ROBERTS EIRY (Chief Medical Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Sold 3,198 shares
@ $107.3758, valued at
$343.4k
|
|
08/23/2023 |
4
| Onyia Jude (Chief Scientific Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Sold 3,198 shares
@ $107.3696, valued at
$343.4k
|
|
08/23/2023 |
4
| Lippoldt Darin (Chief Legal Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Sold 2,132 shares
@ $107.388, valued at
$229k
|
|
08/23/2023 |
4
| GORMAN KEVIN CHARLES (CEO) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Sold 9,328 shares
@ $107.3988, valued at
$1M
|
|
08/23/2023 |
4
| Gano Kyle (Chief Business Development Off) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Sold 2,132 shares
@ $107.4075, valued at
$229k
|
|
08/23/2023 |
4
| Delaet Ingrid (Chief Regulatory Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Sold 1,404 shares
@ $107.4219, valued at
$150.8k
|
|
08/23/2023 |
4
| Cooke Julie (Chief Human Resources Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Sold 2,132 shares
@ $107.4065, valued at
$229k
|
|
08/23/2023 |
4
| Boyer David W. (Chief Corp. Affairs Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Sold 1,600 shares
@ $107.4138, valued at
$171.9k
|
|
08/23/2023 |
4
| BENEVICH ERIC (Chief Commercial Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Sold 1,600 shares
@ $107.3975, valued at
$171.8k
|
|
08/23/2023 |
4
| ABERNETHY MATT (CFO) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Sold 2,132 shares
@ $107.3914, valued at
$229k
|
|
08/22/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/22/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/22/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/22/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/22/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/22/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/22/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/22/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/22/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/22/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/01/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
08/01/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/01/2023 |
8-K
| Quarterly results |
07/13/2023 |
4
| POON CHRISTINE A (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Granted 16,375 options to buy
@ $98.19, valued at
$1.6M
|
|
07/13/2023 |
3
| POON CHRISTINE A (Director) has filed a Form 3 on NEUROCRINE BIOSCIENCES INC |
07/13/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
07/11/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
05/19/2023 |
4
| SHERWIN STEPHEN A (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Granted 4,199 restricted stock units
@ $0 |
|
05/19/2023 |
4
| Sharp Shalini (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Granted 4,290 options to buy
@ $95.27, valued at
$408.7k
Granted 2,100 restricted stock units
@ $0 |
|
05/19/2023 |
4
| RASTETTER WILLIAM H (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Granted 8,579 options to buy
@ $95.27, valued at
$817.3k
|
|
|